abbott laboratories (ABT:New York)
Transactions by ABBOTT LABORATORIES (ABT) in the last 6 months
Prelude Corporation agreed to acquire CynoGen Inc. from Abbott Laboratories (NYSE:ABT) on April 9, 2015.
Abbott Laboratories (NYSE:ABT) acquired UNeLAB from Prairie Ventures, LLC and other shareholders effective December 24, 2014.
Insight Realty Co., Pearlmark Real Estate Partners and Kinship Capital acquired 5301 Patrick Henry Drive in Santa Clara from Abbott Laboratories (NYSE:ABT) on December 19, 2014.
Pearlmark Real Estate Partners
Abbott Laboratories (NYSE:ABT) signed an agreement to acquire Topera, Inc. from Alafi Capital Company LLC, New Enterprise Associates and others for approximately $250 million in cash on October 29, 2014. Under the terms of the agreement Abbott will pay $250 million upfront, plus potential future payments tied to performance milestones. The deal is subject to customary closing conditions, including antitrust clearance. It is expected to close in the fourth quarter of ...
New Enterprise Associates
|AbbVie Inc||$66.07 USD||+1.82|
|AstraZeneca PLC||4,750 GBp||-80.50|
|Danaher Corp||$83.30 USD||-1.39|
|Danone SA||€66.98 EUR||+0.19|
|Thermo Fisher Scientific Inc||$130.02 USD||+0.47|
|View Industry Companies|